Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.
about
Exploiting Genetic Interference for Antiviral TherapyAdvances of gene therapy for primary immunodeficienciesClinical development of gene therapy: results and lessons from recent successesHuman induced pluripotent stem cells for monogenic disease modelling and therapyProduction of lentiviral vectorsCurrent and future alternative therapies for beta-thalassemia majorRecent advances in treatment of severe primary immunodeficienciesTargeted approaches to induce immune tolerance for Pompe disease therapyMegakaryocyte- and megakaryocyte precursor-related gene therapiesGene therapy: progress and predictionsCell-based therapy technology classifications and translational challengesGene therapy for cardiovascular disease: advances in vector development, targeting, and delivery for clinical translationBone Marrow Gene Therapy for HIV/AIDSPerinatal systemic gene delivery using adeno-associated viral vectorsSynthetic biology in mammalian cells: next generation research tools and therapeuticsPrimary cilia in the developing and mature brainAdvances in understanding and treating dystrophic epidermolysis bullosaGene therapy on the moveUnraveling the repertoire in wiskott-Aldrich syndromeThe diagnostic approach to monogenic very early onset inflammatory bowel diseaseAdvances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disordersSystemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targetsGenome editing: the road of CRISPR/Cas9 from bench to clinicGenetically modified mesenchymal stromal cells in cancer therapyRetroviral vectors and transposons for stable gene therapy: advances, current challenges and perspectivesHemophilia A gene therapy via intraosseous delivery of factor VIII-lentiviral vectorsAdvantages and applications of CAR-expressing natural killer cellsManufacture of tumor- and virus-specific T lymphocytes for adoptive cell therapiesTherapeutic genome editing: prospects and challengesGenetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progressionUncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivoRetroviral DNA IntegrationA novel intranuclear RNA vector system for long-term stem cell modificationCharting a clear path: the ASGCT Standardized Pathways ConferenceDNA transposon-based gene vehicles - scenes from an evolutionary driveDevelopment of Hematopoietic Stem Cell Based Gene Therapy for HIV-1 Infection: Considerations for Proof of Concept Studies and Translation to Standard Medical PracticeGene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?Spatiotemporal control of gene expression in bone-marrow derived cells of the tumor microenvironment induced by MRI guided focused ultrasound.Targeted Gene Correction in Osteopetrotic-Induced Pluripotent Stem Cells for the Generation of Functional OsteoclastsEnhancers are major targets for murine leukemia virus vector integration
P2860
Q24288775-904620DB-D6CB-45CE-913A-1D6DD0DE5ECDQ26742031-D9F0B909-7A75-4B51-AD5E-A07FE517E09AQ26743393-93EE5F9E-667B-4F13-B254-DFA0A6C5D49BQ26750393-E059E9D7-7728-4870-97B6-E3A7B8FBA013Q26750586-AA7C1D70-9227-40A2-B233-D0B663FCB990Q26750906-80132DBA-BFAD-42AE-BEEA-8FD4D9EC5C23Q26766170-B1A595E6-8B41-4CFC-AE1B-68672AE91C2AQ26767363-75897250-5F46-4E74-8AFD-5C8911D2D15AQ26770867-4BDADFDF-E506-4EA1-BC51-9DB6BA63BF45Q26772109-0D5DE23D-289C-4F2D-A667-586C8DCCD3F8Q26785346-23F4E348-E4D1-4D0C-A3F4-8E9A8171C2DEQ26799437-FA3F4CB9-8BE3-40CE-AE0E-49D443916557Q26801765-516B89E8-2072-4B3B-A8EE-1E5D6486A6BFQ26852989-26A9752D-C294-4816-908A-A818301A3D35Q26995293-D3628169-414D-43BA-B1DA-369FEB057F2EQ27002324-52D68228-9373-47A1-B362-0CB39EED9DFBQ27006669-BA575E5A-0539-4855-8B43-2A8B4D2516D4Q27007012-7EB1914A-C545-4BF9-8846-39B764766569Q27010095-D85F9A7A-F8C3-443B-AE82-2E540670F52DQ27015077-E242CB08-BB20-491B-8DBA-BE2EEC1F6ED9Q27022561-3DBCF5B5-D4FF-42AF-BA2C-A65055CE8AFFQ27311589-F801BFA1-5F67-4295-8240-949815431A6AQ28066970-3D742324-7AB2-4B7F-BB6D-3BF5551960FCQ28071840-6AF56A70-0D60-494E-A6AF-C5344D63AB16Q28074002-B102430A-FD97-428E-9FE2-3405B360B8A5Q28079890-D01B18E4-4EDA-43CD-8D56-1825E5903CEFQ28080875-F335209E-936D-4CE8-9C23-4162989E8781Q28085769-641EB9FB-5C87-4968-86BC-93E86B501359Q28087380-66AB199B-BBEA-4577-891D-5214181DD716Q28304978-551FF789-1CC9-412B-9690-D1AC6E0291D4Q28383769-5E8DC6FA-6329-451F-8E34-FC1429C4A94BQ28596842-F8F25693-DCDF-412F-9F0C-F2229B24BED1Q28603323-8A3C946B-B5D6-4019-8C40-73B3E70A04D0Q28655957-3631E688-4A7A-4862-82F7-85BB7118022AQ28660891-5F03ED12-1320-47AA-A790-7DD90F9534F4Q29036869-2D2E5490-FD1A-461C-9CDE-F02C16E2699DQ30364488-2EDD0C09-A35B-439E-8962-BA96C0581389Q30393017-B259ECC5-7313-4E2A-8264-BE65D6EB7E17Q30398603-93A0997F-EE89-4478-B692-14F0095500EEQ30429881-501F2F54-149C-4199-AB2B-BED2D91410CF
P2860
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Lentiviral hematopoietic stem ...... with Wiskott-Aldrich syndrome.
@ast
Lentiviral hematopoietic stem ...... with Wiskott-Aldrich syndrome.
@en
Lentiviral hematopoietic stem ...... with Wiskott-Aldrich syndrome.
@nl
type
label
Lentiviral hematopoietic stem ...... with Wiskott-Aldrich syndrome.
@ast
Lentiviral hematopoietic stem ...... with Wiskott-Aldrich syndrome.
@en
Lentiviral hematopoietic stem ...... with Wiskott-Aldrich syndrome.
@nl
prefLabel
Lentiviral hematopoietic stem ...... with Wiskott-Aldrich syndrome.
@ast
Lentiviral hematopoietic stem ...... with Wiskott-Aldrich syndrome.
@en
Lentiviral hematopoietic stem ...... with Wiskott-Aldrich syndrome.
@nl
P2093
P2860
P50
P356
P1433
P1476
Lentiviral hematopoietic stem ...... with Wiskott-Aldrich syndrome.
@en
P2093
Alessandra Biffi
Andrea Assanelli
Ayse Metin
Claudia Benati
Clelia Di Serio
Costanza Evangelio
Cristina Baricordi
Danilo Pellin
David J Dow
P2860
P304
P356
10.1126/SCIENCE.1233151
P407
P50
P577
2013-07-11T00:00:00Z